These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30213303)

  • 61. [Immunopathology of Graves'-Basedow disease].
    Baj Z; Ferenc T; Lewiński A
    Postepy Hig Med Dosw; 1997; 51(5):531-46. PubMed ID: 9489453
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [TBL] [Abstract][Full Text] [Related]  

  • 63. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy.
    Bahn RS
    J Endocrinol Invest; 2004 Mar; 27(3):216-20. PubMed ID: 15164996
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
    Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of TSH receptor antibodies in the management of Graves' disease.
    Matthews DC; Syed AA
    Eur J Intern Med; 2011 Jun; 22(3):213-6. PubMed ID: 21570635
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization.
    Wu SL; Yang CS; Wang HJ; Liao CL; Chang TJ; Chang TC
    J Endocrinol Invest; 1999 Apr; 22(4):289-95. PubMed ID: 10342363
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor.
    Okamoto Y; Yanagawa T; Fisfalen ME; DeGroot LJ
    Thyroid; 1994; 4(1):37-42. PubMed ID: 7519915
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genotypes in relation to phenotypic appearance and exposure to environmental factors in Graves' hyperthyroidism.
    Vos XG; Endert E; Tijssen JG; Wiersinga WM
    Eur J Endocrinol; 2012 Dec; 167(6):783-92. PubMed ID: 22968483
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
    Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
    Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease.
    Hodge SE; Ban Y; Strug LJ; Greenberg DA; Davies TF; Concepcion ES; Villanueva R; Tomer Y
    Thyroid; 2006 Apr; 16(4):351-5. PubMed ID: 16646680
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of single nucleotide polymorphism in CD28(C/T-I3 + 17) and CD40 (C/T-1) genes with the Graves' disease.
    Mustafa S; Fatima H; Fatima S; Khosa T; Akbar A; Shaikh RS; Iqbal F
    J Pak Med Assoc; 2018 Jan; 68(1):3-9. PubMed ID: 29371709
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.
    Struja T; Kutz A; Fischli S; Meier C; Mueller B; Recher M; Schuetz P
    BMC Med; 2017 Sep; 15(1):174. PubMed ID: 28942732
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Graves' ophthalmopathy: pathogenesis and clinical implications.
    Major BJ; Busuttil BE; Frauman AG
    Aust N Z J Med; 1998 Feb; 28(1):39-45. PubMed ID: 9544385
    [No Abstract]   [Full Text] [Related]  

  • 75. Graves' ophthalmopathy: a preventable disease?
    Bartalena L; Marcocci C; Pinchera A
    Eur J Endocrinol; 2002 Apr; 146(4):457-61. PubMed ID: 11916611
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of immune regulatory genes' copy number variants in Graves' disease.
    Huber AK; Concepcion ES; Gandhi A; Menconi F; Smith EP; Keddache M; Tomer Y
    Thyroid; 2011 Jan; 21(1):69-74. PubMed ID: 21054240
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A case of carotid cavernous fistula mimicking Graves' orbitopathy.
    Cosentino G; Comi S; Maglionico MN; Marinò M
    J Endocrinol Invest; 2024 Jan; 47(1):255-256. PubMed ID: 37347382
    [No Abstract]   [Full Text] [Related]  

  • 78. Graves' disease with thyrotoxicosis following subacute thyroiditis.
    Wartofsky L; Schaaf M
    Am J Med; 1987 Oct; 83(4):761-4. PubMed ID: 3674062
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Graves' disease: introducing new genetic and epigenetic contributors.
    Razmara E; Salehi M; Aslani S; Bitaraf A; Yousefi H; Colón JR; Mahmoudi M
    J Mol Endocrinol; 2021 Feb; 66(2):R33-R55. PubMed ID: 33295879
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Acute autoimmune myocarditis secondary to Graves' disease: a case report].
    Demoulin R; Poyet R; Parsai C; Capilla E; Rohel G; Pons F; Jego C; Cellarier GR
    Rev Med Interne; 2020 Mar; 41(3):206-209. PubMed ID: 31982255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.